Bittium Exhibits its High-Tech Medical Technology Products and R&D Services for Medical and Healthcare Technology

BittiumBittium exhibits its innovative products and solutions for cardiology and neurophysiology as well as R&D services for the development of medical and healthcare technology at the MEDICA 2021 event. It is the world's biggest trade fair for the medical market, and it will be organized in Düsseldorf, Germany on November 15-18, 2021.

Bittium's team of Medical Technologies experts are showcasing advanced high-tech solutions for monitoring of heart, brain and sleeping disorders. The solutions enable early detection of abnormalities in body's electrical activities and sleep-related breathing disorders, thus speeding up the diagnosis and further treatment of a patient. All Bittium's cardiology, neurophysiology and sleeping disorder measurement solutions are integrated with the cloud-based back-end systems that enable the analysis of data regardless of location.

Bittium's team of R&D services experts are showcasing services for medical and healthcare technology that enable for example the development of innovative wireless devices that use the latest technologies and can be used in or outside the hospital. Customers using the R&D services benefit from Bittium’s strong expertise and experience in all stages of product development, including versatile know-how of both hardware and software, as well as specialized expertise in wireless connectivity and information security. The high quality of the product development projects is based on processes carried out according to the ISO 13485 certificate.

The Medical Technologies team is located at stand 9/C15 exhibiting the following products and solutions:

Products and solutions for cardiology:

  • Bittium Faros™ ECG measuring and monitoring device
  • Bittium Cardiac Navigator™ analysis software for ECG measurement data
  • Bittium OmegaSnap™ a family of disposable ECG patch electrodes
  • Bittium HolterPlus™ web-based remote cardiac monitoring solution

Products and solutions for neurophysiology:

  • Bittium BrainStatus™ a compact EEG measuring and monitoring system
  • Bittium BrainStatus™ with Cerenion C-Trend for measuring the brain function of intensive care patients
  • Bittium NeurOne™ the most accurate EEG measuring device
  • Bittium Respiro™ a modern sleep apnea screening device and analysis service solution
  • Bittium Respiro Analyst™ analysis software for sleep apnea measurement data

Visit https://www.bittium.com/medical for more information on the offering.

The R&D services team is located at stand 12/D21 and exhibiting the following solutions:

  • Wireless solutions - One of Bittium’s core competencies is mastering different radio and antenna technologies and their application to different solutions using wireless connectivity. Bittium's in-house RF and antenna test laboratories support the development work and enable comprehensive project deliveries to the customers.
  • Innovative, power-optimized devices - Bittium specializes in the development of small, power-optimized devices that include different sensors. The device development expertise is complemented with strong know-how of embedded software and the combination enables development of different types of systems for demanding environments.
  • Standards-based services - The high quality of Bittium’s R&D services is based on processes carried out according to the ISO 13485 certificate, and Bittium’s in-house test laboratories are utilized in the verification and validation of the products.

Visit https://www.bittium.com/rd-services/healthcare-medical for more information on the offering.

About Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35 years’ legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki.

Most Popular Now

AI in Personalized Cancer Medicine: New …

The application of AI in precision oncology has so far been largely confined to the development of new drugs and had only limited impact on the personalisation of therapies. New...

AI can Predict Brain Cancer Patients…

Artificial Intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months after receiving radiotherapy treatment. The use of the AI to successfully predict patient outcomes...

Max Planck Institute for Informatics and…

The Max Planck Institute for Informatics and Google deepen their strategic research partnership. With additional financial support from the U.S. IT company, the "Saarbrücken Research Center for Visual Computing, Interaction...

JMIR Medical Informatics Invites Submiss…

JMIR Publications has announced a new section titled, "AI Language Models in Health Care" in JMIR Medical Informatics. This leading peer-reviewed journal is indexed in PubMed and has a unique...

Paper Calls for Patient-First Regulation…

Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life? A new study published in JAMA...

Could ChatGPT Help or Hurt Scientific Re…

Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short...

Evaluating the Performance of AI-Based L…

A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint the area of treatment requires significant time...

Making AI a Partner in Neuroscientific D…

The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence...

Chapman Scientists Code ChatGPT to Desig…

Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails - it can also design...

DMEA nova Award: Wanted - Visionary Solu…

9 - 11 April 2024, Berlin, Germany. The DMEA nova Award is being presented at DMEA 2024 for the first time. The award honours a digital health startup for an outstanding...

New Digital Therapy Reduces Anxiety and …

A therapist-guided digital cognitive behavioural therapy reduced distress in 89 per cent of participants living with long-term physical health conditions, a new King's College London study finds. Researchers at the Institute...

Europe's Digital Health Industry Me…

9 - 11 April 2024, Berlin, Germany. In just over two months, from 9 to 11 April 2024, DMEA, Europe's leading event for digitalisation of healthcare, will gather digital health experts...